Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. SymBio Pharmaceuticals Limited
  6. Company
    4582   JP3383050006

SYMBIO PHARMACEUTICALS LIMITED

(4582)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The Company develops new medicines using chemical compounds proofed by preclinical tests and clinical tests. The Company manufactures and sells medicines through domestic and foreign pharmaceutical companies. The Company's pipelines include anticancer drugs, such as SyB L-0501, SyB L-1101 and SyB C-1101.

Number of employees : 127 people.
Sales per Business
20192020Delta
Pharmaceuticals2 837.75100%2 987.05100% +5.26%
JPY in Million
Sales per region
20192020Delta
Japan2 837.75100%2 987.05100% +5.26%
JPY in Million
Managers
Name Title Age Since
Fuminori Yoshida President, CEO & Representative Director 72 2005
Takaaki Fukushima Chief Financial Officer & Executive Officer - -
Shigetoshi Matsumoto Independent Outside Director 72 2018
Members of the board
Name Title Age Since
Fuminori Yoshida President, CEO & Representative Director 72 2005
Shigetoshi Matsumoto Independent Outside Director 72 2018
Bruce David Cheson Outside Director 75 2019
Eiji Ebinuma Outside Director 64 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 38,445,931 34,994,252 91.0% 76,868 0.2% 91.0%
Shareholders
NameEquities%
Shin Takahashi 1,187,000 3.09%
Fuminori Yoshida 1,074,700 2.80%
Norihiro Kuroda 452,300 1.18%
Daisuke Ogawa 402,500 1.05%
Hitoshi Imamura 239,300 0.62%
Eisai Co., Ltd. 208,350 0.54%
SymBio Pharmaceuticals Limited 76,800 0.20%
Daiwa Asset Management Co. Ltd. 62,598 0.16%
SSgA Funds Management, Inc. 61,800 0.16%
Holdings
NameEquities%Valuation
SYMBIO PHARMACEUTICALS LIMITED (4582) 76,800 0.20% 706,911 USD
Company contact information
SymBio Pharmaceuticals Ltd.
Toranomon 30 Mori Building
3-2-2 Toranomon
Minato-Ku
Tokyo 105-0001

Phone : +81.3.5472.1125
Fax : +81.3.5472.3054
Web : http://www.symbiopharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of SymBio Pharmaceuticals Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
SYMBIO PHARMACEUTICALS LIMITED187.86%368
JOHNSON & JOHNSON4.04%431 043
ROCHE HOLDING AG14.74%335 888
NOVO NORDISK A/S59.43%242 507
PFIZER, INC.18.34%240 919
ELI LILLY AND COMPANY48.17%226 799
MERCK & CO., INC.-0.32%206 408
ABBVIE INC.1.17%191 562
ASTRAZENECA PLC22.80%191 297
NOVARTIS AG-9.12%185 170
BRISTOL-MYERS SQUIBB COMPANY-8.93%125 527
SANOFI8.98%124 766
AMGEN INC.-10.15%117 307
GLAXOSMITHKLINE PLC7.44%99 076
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-21.86%62 127
BAYER AG0.91%55 326
JIANGSU HENGRUI MEDICINE CO., LTD.-47.18%48 909
DAIICHI SANKYO COMPANY, LIMITED-18.42%48 573
TAKEDA PHARMACEUTICAL COMPANY LIMITED-15.02%44 093
ASTELLAS PHARMA INC.23.43%32 037